View of POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME

Return to Article Details POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME Download Download PDF